Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Deal Watch: AbbVie, arGEN-X To Explore Immuno-Oncology According To GARP

Executive Summary

Also during a busy two-week stretch, AbbVie signs a partnership to co-develop drug conjugate products with CytomX, acquires privately held Stemcentrx, and agrees to a broad-based five-year cancer research collaboration with University of Chicago. Sanofi makes formal bid to acquire Medivation, which is rejected.

Advertisement

Related Content

AstraZeneca’s Ardea Acquisition: A Rich Deal Spurred By Phase III Gout Candidate

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register